For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
Pooled 10-donor, male human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Pooled 10-donor, mixed-gender human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Pooled 20-donor male only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
-
Instructions - UltraCHO™ MediumHow to use ProCHO medium
-
Instructions – ProCHO Liquid mediaInstructions for use of ProCHO Media
-
Instructions ProCHO powder kitsInstructions for use of ProCHO Powder kits
-
ProCHO® Protein Expression Media
-
PowerCHO® Protein Expression Media brochureOverview of the PoweCHO medium (new PowerCHO Advanced not included)
-
WinKQCL™ 5 Remote Client Installation InstructionsWinKQCL™ 5 client installation system requirements and configuration.
-
WinKQCL 5 Software - EnglishWe Analyze Endotoxin Data Every Day Version 5 Software Features Announcement of discontinued support for Windows SQL Server® 2000 and XP Operating System English Version
-
WinKQCL™ 5 Endotoxin Detection SoftwareLearn how to use the advanced features in Lonza's WinKQCL™ Endotoxin Detection Software to save time, reduce costs and ensure compliance to 21 CFR Part 11 and Annex 11. -
BE02-056Q CHO Xtreme™ Feed CD - InstructionsBE02-056Q
-
4D-Nucleofector® Protocol for MRC-5Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for MRC-5